Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa

Alvarez Lerma, Francisco; Muñoz Bermudez, Rosana; Grau, Santiago; Gracia Arnillas, María Pilar; Sorli, Luisa; Recasens, Lluis; Mico García, Miquel.
Rev. esp. quimioter ; 30(3): 224-228, jun. 2017. tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-163235

Documentos relacionados

  1. Implementing paediatric appropriate use criteria for endotracheal suction to reduce complications in mechanically ventilated children with respiratory infections.
  2. Multiplex detection of five common respiratory pathogens from bronchoalveolar lavages using high resolution melting curve analysis.
  3. Impact of Organism Reporting from Endotracheal Aspirate Cultures on Antimicrobial Prescribing Practices in Mechanically Ventilated Pediatric Patients.
  4. The respiratory microbiota during and following mechanical ventilation for respiratory infections in children.
  5. Bacterial immunotherapy is highly effective in reducing recurrent upper respiratory tract infections in children: a prospective observational study.
  6. Effectiveness of filtering or decontaminating air to reduce or prevent respiratory infections: A systematic review.
  7. Healthcare-associated respiratory tract infection.
  8. Viral Respiratory Infection, a Risk in Pediatric Cardiac Surgery: A Propensity-Matched Analysis.
  9. In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies).
  10. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.